Huntington’s Disease Clinical Trials Corner: August 2023
Carlos Estevez‐Fraga, Sarah J. Tabrizi, Edward J. Wild
Abstract
In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington's disease.
Topics & Concepts
Clinical trialDiseaseMedicineHuntington's diseaseInternal medicineGenetic Neurodegenerative DiseasesMitochondrial Function and PathologyNeurological disorders and treatments